I. Garcia del Valle, M. Sanmartín Suñer, L. Val Prat, M. Nevot Blanc, P. Marcos Pascua, G. Morla Clavero, M. Garcia Pelaez, G. Baronet Jordana
{"title":"优化SARS-CoV-2大流行期间重症监护病房的镇痛作用","authors":"I. Garcia del Valle, M. Sanmartín Suñer, L. Val Prat, M. Nevot Blanc, P. Marcos Pascua, G. Morla Clavero, M. Garcia Pelaez, G. Baronet Jordana","doi":"10.1136/ejhpharm-2022-eahp.379","DOIUrl":null,"url":null,"abstract":"Background and importanceThe pandemic caused by SARS-CoV-2 evidenced the need for expediting the dispensation and usage process, poorly automated, of narcotic drugs and for optimising the most commonly used perfusions available in the hospital (midazolam, dexmedethomidine, propofol, fentanyl). With this intervention, significant improvements in efficacy and safety were expected, considering the fact that perfusions decrease the risk of infection, medication errors and the workload and exposure of nurses.Aim and objectivesTo elaborate a physicochemical and microbiological stable fentanyl perfusion and to adapt the presentations of drugs (midazolam, dexmedethomidine, propofol, fentanyl) used for analgosedation in COVID-19 patients admitted to the intensive care unit (ICU).Material and methodsA multidisciplinary team formed by intensive care doctors, nurses and clinical pharmacists was created in October 2020 to discuss areas of improvement and effort optimisation.All midazolam and propofol presentations were changed for others of larger volume available on the market. A dexmedethomidine perfusion 2000 mg/250 mL was standardised thanks to previous stability data collected.A new fentanyl perfusion was prepared and validated in sterile conditions after a literature systematic review, microbiological controls in tryptic soy broth (TSB) and thioglycollate broth, and a microbiological risk matrix were done.Fentanyl perfusions were stocked in Pharmacy and individually dispensed according to the infusion speed of each patient. Control numbers were assigned to every preparation to maintain the narcotics’ traceability.ResultsEach perfusion consisted of 1500 μg fentanyl (10 vials 150 μg/3 ml=1 perfusion) diluted in 100 mL sodium chloride 0.9%. The final stability given was 30 days at room temperature (all culture replicates in TSB and thioglycollate broth at days 0, 9 and 30 were negative). The daily number of preparations depended on the epidemiology of the disease. However, a median value of 13 perfusions was dispensed up to a total of 21 ICU beds.Conclusion and relevanceThis model can be extrapolated to other Pharmacy Services as long as volumetric pumps, trained professionals and horizontal laminar flow cabinets are available. The intervention met some of the demands created during the pandemic and helped to slightly attenuate the pressure on healthcare professionals.References and/or acknowledgementsConflict of interestNo conflict of interest","PeriodicalId":393937,"journal":{"name":"Section 7: Post Congress additions","volume":"64 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"3PC-032 Optimising analgosedation in the intensive care unit during the SARS-CoV-2 pandemic\",\"authors\":\"I. Garcia del Valle, M. Sanmartín Suñer, L. Val Prat, M. Nevot Blanc, P. Marcos Pascua, G. Morla Clavero, M. Garcia Pelaez, G. Baronet Jordana\",\"doi\":\"10.1136/ejhpharm-2022-eahp.379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and importanceThe pandemic caused by SARS-CoV-2 evidenced the need for expediting the dispensation and usage process, poorly automated, of narcotic drugs and for optimising the most commonly used perfusions available in the hospital (midazolam, dexmedethomidine, propofol, fentanyl). With this intervention, significant improvements in efficacy and safety were expected, considering the fact that perfusions decrease the risk of infection, medication errors and the workload and exposure of nurses.Aim and objectivesTo elaborate a physicochemical and microbiological stable fentanyl perfusion and to adapt the presentations of drugs (midazolam, dexmedethomidine, propofol, fentanyl) used for analgosedation in COVID-19 patients admitted to the intensive care unit (ICU).Material and methodsA multidisciplinary team formed by intensive care doctors, nurses and clinical pharmacists was created in October 2020 to discuss areas of improvement and effort optimisation.All midazolam and propofol presentations were changed for others of larger volume available on the market. A dexmedethomidine perfusion 2000 mg/250 mL was standardised thanks to previous stability data collected.A new fentanyl perfusion was prepared and validated in sterile conditions after a literature systematic review, microbiological controls in tryptic soy broth (TSB) and thioglycollate broth, and a microbiological risk matrix were done.Fentanyl perfusions were stocked in Pharmacy and individually dispensed according to the infusion speed of each patient. Control numbers were assigned to every preparation to maintain the narcotics’ traceability.ResultsEach perfusion consisted of 1500 μg fentanyl (10 vials 150 μg/3 ml=1 perfusion) diluted in 100 mL sodium chloride 0.9%. The final stability given was 30 days at room temperature (all culture replicates in TSB and thioglycollate broth at days 0, 9 and 30 were negative). The daily number of preparations depended on the epidemiology of the disease. However, a median value of 13 perfusions was dispensed up to a total of 21 ICU beds.Conclusion and relevanceThis model can be extrapolated to other Pharmacy Services as long as volumetric pumps, trained professionals and horizontal laminar flow cabinets are available. The intervention met some of the demands created during the pandemic and helped to slightly attenuate the pressure on healthcare professionals.References and/or acknowledgementsConflict of interestNo conflict of interest\",\"PeriodicalId\":393937,\"journal\":{\"name\":\"Section 7: Post Congress additions\",\"volume\":\"64 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 7: Post Congress additions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2022-eahp.379\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 7: Post Congress additions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2022-eahp.379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景和重要性SARS-CoV-2引起的大流行证明有必要加快麻醉药品的分配和使用流程(自动化程度较低),并优化医院最常用的输液(咪达唑仑、右美托咪定、异丙酚、芬太尼)。考虑到输液降低了感染、用药错误的风险以及护士的工作量和暴露,这种干预措施有望显著改善疗效和安全性。目的和目的探讨一种物理化学和微生物学稳定的芬太尼灌注,并适应新冠肺炎重症监护病房(ICU)患者镇痛镇静药物(咪达唑仑、右美托咪定、异丙酚、芬太尼)的使用情况。材料和方法由重症监护医生、护士和临床药剂师组成的多学科团队于2020年10月成立,讨论改进和优化工作的领域。所有咪达唑仑和异丙酚的表现都被市场上其他更大的容量所改变。根据先前收集的稳定性数据,标准化右美托咪定灌注2000 mg/250 mL。通过文献系统综述、胰蛋白酶豆汤(TSB)和巯基乙酸酯肉汤的微生物对照以及微生物风险矩阵,制备了新的芬太尼灌注液,并在无菌条件下进行了验证。药房存放芬太尼输液,并根据每位患者的输液速度单独配药。为保证麻醉品的可追溯性,每种制剂都分配了控制编号。结果每次灌注1500 μg芬太尼(10瓶,150 μg/ 3ml =1次灌注),用100 ml 0.9%氯化钠稀释。室温下的最终稳定性为30天(在TSB和巯基乙酸酯肉汤中0、9和30天的所有培养重复均为阴性)。每天的制剂数量取决于疾病的流行病学。然而,中位数为13次灌注,共分配了21个ICU床位。结论和相关性只要有容积泵、训练有素的专业人员和水平层流柜,该模型可以推广到其他药学服务。干预措施满足了大流行期间产生的一些需求,并有助于略微减轻保健专业人员的压力。参考文献和/或致谢利益冲突无利益冲突
3PC-032 Optimising analgosedation in the intensive care unit during the SARS-CoV-2 pandemic
Background and importanceThe pandemic caused by SARS-CoV-2 evidenced the need for expediting the dispensation and usage process, poorly automated, of narcotic drugs and for optimising the most commonly used perfusions available in the hospital (midazolam, dexmedethomidine, propofol, fentanyl). With this intervention, significant improvements in efficacy and safety were expected, considering the fact that perfusions decrease the risk of infection, medication errors and the workload and exposure of nurses.Aim and objectivesTo elaborate a physicochemical and microbiological stable fentanyl perfusion and to adapt the presentations of drugs (midazolam, dexmedethomidine, propofol, fentanyl) used for analgosedation in COVID-19 patients admitted to the intensive care unit (ICU).Material and methodsA multidisciplinary team formed by intensive care doctors, nurses and clinical pharmacists was created in October 2020 to discuss areas of improvement and effort optimisation.All midazolam and propofol presentations were changed for others of larger volume available on the market. A dexmedethomidine perfusion 2000 mg/250 mL was standardised thanks to previous stability data collected.A new fentanyl perfusion was prepared and validated in sterile conditions after a literature systematic review, microbiological controls in tryptic soy broth (TSB) and thioglycollate broth, and a microbiological risk matrix were done.Fentanyl perfusions were stocked in Pharmacy and individually dispensed according to the infusion speed of each patient. Control numbers were assigned to every preparation to maintain the narcotics’ traceability.ResultsEach perfusion consisted of 1500 μg fentanyl (10 vials 150 μg/3 ml=1 perfusion) diluted in 100 mL sodium chloride 0.9%. The final stability given was 30 days at room temperature (all culture replicates in TSB and thioglycollate broth at days 0, 9 and 30 were negative). The daily number of preparations depended on the epidemiology of the disease. However, a median value of 13 perfusions was dispensed up to a total of 21 ICU beds.Conclusion and relevanceThis model can be extrapolated to other Pharmacy Services as long as volumetric pumps, trained professionals and horizontal laminar flow cabinets are available. The intervention met some of the demands created during the pandemic and helped to slightly attenuate the pressure on healthcare professionals.References and/or acknowledgementsConflict of interestNo conflict of interest